Is ICER NICEr?
Pharmacoeconomics
.
2018 Apr;36(4):385-386.
doi: 10.1007/s40273-018-0617-6.
Authors
Deborah Freund
1
,
Jennifer Choi
2
Affiliations
1
Claremont Graduate University, Claremont, CA, USA. debbie.freund@cgu.edu.
2
Department of Economic Sciences, Claremont Graduate University, Claremont, CA, USA.
PMID:
29468408
DOI:
10.1007/s40273-018-0617-6
No abstract available
Publication types
Editorial
MeSH terms
Cost-Benefit Analysis*
Drug Costs / trends*
Humans
Organizations / standards*